Buy Stocks Easy | About Us
August 15, 2020
Buy Stocks Easy | Online Stocks

ONTX


Buy Onconova Therapeutics, Inc. Stock (symbol: ONTX) Easy Online

Company Name: Onconova Therapeutics, Inc.

Symbol: ONTX

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2001

ONTX Current Share Price

Today's ONTX ( Onconova Therapeutics, Inc. ) opening price: $

Yesterday's ONTX ( Onconova Therapeutics, Inc. ) closing price: $

Onconova Therapeutics, Inc. Stock ( symbol: ONTX ) Price Chart since IPO (2001):

12 Months Onconova Therapeutics, Inc. Stock ( symbol: ONTX ) Price Chart

Popular Questions about Onconova Therapeutics, Inc. Public Stock ( ONTX )

A: Onconova Therapeutics, Inc. stock symbol (also called stock or share ticker) is ONTX

A: Onconova Therapeutics, Inc. IPO (Initial Public Offering) took place on 2001

A: Onconova Therapeutics, Inc.'s stock (ONTX symbol) price at ther IPO (initial Public Offering) was $

Q: Is ONTX stock worth buying at the moment?

A: The ONTX stock performance since 2019 are rather disappointing. If you had bought 1 share of Onconova Therapeutics, Inc. stock (symbol: ONTX) at the beginning of 2019, at the opening share price of $3.1000, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Onconova Therapeutics, Inc. Stock Easy Online

Onconova Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Onconova Therapeutics, Inc. Stock Price Yesterday



 


Onconova Therapeutics, Inc. Stock Price – Last Week




 


Onconova Therapeutics, Inc. Stock Price – Last Month




 


Onconova Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/03/1966111/0/en/Onconova-Therapeutics-Inc-Announces-Closing-of-10-Million-Registered-Direct-Offering-of-Common-Stock-Priced-At-The-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market

                                
                                
NEWTOWN, Pa., Jan.  03, 2020  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/31/1965391/0/en/Onconova-Therapeutics-Inc-Announces-10-Million-Registered-Direct-Offering-Priced-At-The-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market

                                
                                
NEWTOWN, Pa., Dec.  31, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1963062/0/en/Onconova-Therapeutics-Inc-Announces-Closing-Of-5-0-Million-Registered-Direct-Offering-Priced-At-The-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces Closing Of $5.0 Million Registered Direct Offering Priced At-The-Market

                                
                                
NEWTOWN, Pa., Dec.  19, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962252/0/en/Onconova-Therapeutics-Inc-Announces-5-0-Million-Registered-Direct-Offering-Priced-At-the-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market

                                
                                
NEWTOWN, Pa., Dec.  18, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961495/0/en/Onconova-Therapeutics-and-Pint-Pharma-Announce-Brazilian-Health-Authority-Approval-for-Initiating-INSPIRE-Trial-with-Intravenous-Rigosertib-in-Higher-Risk-Myelodysplastic-Syndromes.html
                            

                                
Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in Brazil

                                
                                
NEWTOWN, Pa., Dec.  17, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/10/1958876/0/en/Onconova-Therapeutics-Inc-Announces-Closing-of-5-0-Million-Registered-Direct-Offering-Priced-At-the-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market.

                                
                                
NEWTOWN, Pa., Dec.  10, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957938/0/en/Onconova-Therapeutics-Announces-Data-on-Genomic-Profiles-of-Higher-Risk-Myelodysplastic-Syndromes-Patients-Refractory-to-Azacitidine-Therapy-Enrolled-into-the-Pivotal-INSPIRE-Trial.html
                            

                                
Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical T

                                
                                
NEWTOWN, Pa., Dec.  09, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957858/0/en/Onconova-Therapeutics-Inc-Announces-5-0-Million-Registered-Direct-Offering-Priced-At-the-Market.html
                            

                                
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market.

                                
                                
NEWTOWN, Pa., Dec.  09, 2019  (GLOBE NEWSWIRE) -- Onconova Therapeu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/06/1957268/0/en/Inceptua-Medicines-Access-and-Onconova-Therapeutics-Announce-Pre-approval-Access-Collaboration-for-Rigosertib-in-Selected-Countries-Outside-the-US.html
                            

                                
Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US

                                
                                
NEWTOWN, Pa. and LUXEMBOURG, Dec.  06, 2019  (GLOBE NEWSWIRE) -- On...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1952058/0/en/Onconova-Therapeutics-Inc-Announces-Closing-of-11-0-Million-Public-Offering.html
                            

                                
Onconova Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering

                                
                                
Offering led by healthcare dedicated funds, including Knight Therap...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.